Anna Furlan

662 total citations
16 papers, 162 citations indexed

About

Anna Furlan is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Anna Furlan has authored 16 papers receiving a total of 162 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Hematology and 5 papers in Molecular Biology. Recurrent topics in Anna Furlan's work include Multiple Myeloma Research and Treatments (4 papers), Diabetic Foot Ulcer Assessment and Management (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Anna Furlan is often cited by papers focused on Multiple Myeloma Research and Treatments (4 papers), Diabetic Foot Ulcer Assessment and Management (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Anna Furlan collaborates with scholars based in Italy, United Kingdom and United States. Anna Furlan's co-authors include Filíppo Gherlinzoni, Piergiorgio Scotton, Gabriella Forner, Elisa Vian, Ludovica Cipriani, Roberto Rigoli, Fabrizio Vianello, Maurizio Clementi, Giuseppe Tognon and Agostino Paccagnella and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Diabetes Care.

In The Last Decade

Anna Furlan

14 papers receiving 159 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Furlan Italy 8 44 39 38 26 26 16 162
Alain Mina United States 9 69 1.6× 70 1.8× 19 0.5× 31 1.2× 26 1.0× 31 201
Hajime Senjo Japan 9 45 1.0× 54 1.4× 23 0.6× 30 1.2× 49 1.9× 31 222
Kar Fai Chow United States 8 46 1.0× 38 1.0× 23 0.6× 50 1.9× 82 3.2× 20 159
Serkan Akın Türkiye 9 38 0.9× 133 3.4× 18 0.5× 14 0.5× 31 1.2× 50 310
Fatma Visal Okur Türkiye 9 29 0.7× 55 1.4× 8 0.2× 23 0.9× 60 2.3× 22 186
Juan José Borrero Martín Spain 8 32 0.7× 60 1.5× 17 0.4× 15 0.6× 27 1.0× 32 184
Pablo Tutor‐Ureta Spain 10 35 0.8× 28 0.7× 19 0.5× 12 0.5× 28 1.1× 29 320
Jennifer Amsler Switzerland 7 23 0.5× 60 1.5× 111 2.9× 31 1.2× 26 1.0× 12 271
Ryosuke Shirasaki Japan 6 63 1.4× 49 1.3× 16 0.4× 26 1.0× 20 0.8× 33 156
Julie Oniszczuk France 9 38 0.9× 14 0.4× 17 0.4× 36 1.4× 45 1.7× 18 218

Countries citing papers authored by Anna Furlan

Since Specialization
Citations

This map shows the geographic impact of Anna Furlan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Furlan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Furlan more than expected).

Fields of papers citing papers by Anna Furlan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Furlan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Furlan. The network helps show where Anna Furlan may publish in the future.

Co-authorship network of co-authors of Anna Furlan

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Furlan. A scholar is included among the top collaborators of Anna Furlan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Furlan. Anna Furlan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
D’Agostino, Mattia, Marina Martello, Lorenzo De Paoli, et al.. (2025). Overview of 1q abnormalities in multiple myeloma: scientific opinions from Italian experts. Annals of Hematology. 104(3). 1443–1458. 1 indexed citations
2.
Gaballa, Mahmoud, Nobuhiro Tsukada, Kazuhito Suzuki, et al.. (2024). Real-World Experience with Isatuximab in Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM): Iona-MM Second Interim Analysis. Blood. 144(Supplement 1). 2411.5–2411.5. 1 indexed citations
3.
4.
Pradelli, Lorenzo, Massimo Massaia, Elisabetta Todisco, et al.. (2023). Improved efficiency of daratumumab treatment of multiple myeloma adopting the subcutaneous route: A micro‐costing analysis in three Italian hematology centers. Cancer Medicine. 12(23). 21480–21489. 6 indexed citations
5.
6.
Furlan, Anna, Gabriella Forner, Ludovica Cipriani, et al.. (2021). COVID-19 in B Cell-Depleted Patients After Rituximab: A Diagnostic and Therapeutic Challenge. Frontiers in Immunology. 12. 763412–763412. 40 indexed citations
7.
Furlan, Anna, Gabriella Forner, Ludovica Cipriani, et al.. (2021). Dramatic Response to Convalescent Hyperimmune Plasma in Association With an Extended Course of Remdesivir in 4 B Cell–Depleted Non-Hodgkin Lymphoma Patients With SARS-Cov-2 Pneumonia After Rituximab Therapy. Clinical Lymphoma Myeloma & Leukemia. 21(9). e731–e735. 12 indexed citations
8.
9.
10.
Sambataro, Maria, Luisa Sambado, Matilde Cacciatore, et al.. (2018). Proinsulin‐expressing dendritic cells in type 2 neuropathic diabetic patients with and without foot lesions. The FASEB Journal. 32(7). 3742–3751. 3 indexed citations
11.
Puccini, Benedetta, Luca Nassi, Carla Minoia, et al.. (2017). Role of bone marrow biopsy in staging of patients with classical Hodgkin’s lymphoma undergoing positron emission tomography/computed tomography. Annals of Hematology. 96(7). 1147–1153. 11 indexed citations
12.
Sambataro, Maria, Fabio Canal, Anna Furlan, et al.. (2014). Prognostic Significance of Circulating and Endothelial Progenitor Cell Markers in Type 2 Diabetic Foot. International Journal of Vascular Medicine. 2014. 1–7. 12 indexed citations
13.
14.
Furlan, Anna, et al.. (2009). Low-dose fludarabine increases rituximab cytotoxicity in B-CLL cells by triggering caspases activationin vitro. Leukemia & lymphoma. 51(1). 107–113. 11 indexed citations
15.
Furlan, Anna, Fabrizio Vianello, Maurizio Clementi, & Paolo Prandoni. (2006). Heparin- induced thrombocytopenia occurring in the first trimester of pregnancy: successful treatment with lepirudin. A case report.. PubMed. 91(8 Suppl). ECR40–ECR40. 12 indexed citations
16.
Magaraggia, Michela, Adriana Visonà, Anna Furlan, et al.. (2005). Inactivation of vascular smooth muscle cells photosensitised by liposome-delivered Zn(II)–phthalocyanine. Journal of Photochemistry and Photobiology B Biology. 82(1). 53–58. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alain Mina Breakdown of academic impact, for papers by Hajime Senjo Breakdown of academic impact, for papers by Kar Fai Chow Breakdown of academic impact, for papers by Serkan Akın Breakdown of academic impact, for papers by Fatma Visal Okur Breakdown of academic impact, for papers by Juan José Borrero Martín Breakdown of academic impact, for papers by Pablo Tutor‐Ureta Breakdown of academic impact, for papers by Jennifer Amsler Breakdown of academic impact, for papers by Ryosuke Shirasaki Breakdown of academic impact, for papers by Julie Oniszczuk
Rankless by CCL
2026